Omar Zaher
Forschungsgebiet
|
Lebenslauf
Seit 01/2024: Doktorand in der Klinischen Pharmazie, Universität des Saarlandes, Saarbrücken
06/2021 – 08/2021: Praktikum, Pharmacometrics research group, Universität Uppsala, Schweden
09/2020 – 08/2022: Master of pharmaceutical modeling, Universität Uppsala, Schweden
08/2018 – 08/2020: Senior product specialist, Sanofi Genzyme, Saudi-Arabien
06/2011 – 06/2018: Neurology product specialist, Biogen, Ägypten, Saudi-Arabien
01/2010 – 05/2011: Oncology medical representative, Hospira, Ägypten
09/2005 – 06/2009: Studium der Pharmazie, Alexandria University, Faculty of pharmacy, Ägypten
Publikationen
Manuskripte
Walle N, Dings C, Zaher O, Doerr AA, Peters B, Laschke MW, Lehr T, Menger MD, Schmidt PH, Meyer MR, Schaefer N. Does a carboxamide moiety alter the toxicokinetics of synthetic cannabinoids? A study after pulmonary and intravenous administration of cumyl-5F-P7AICA to pigs. Arch Toxicol. 2025. doi:10.1007/s00204-024-03906-z Centanni M, Zaher O, Elhad D, Karlsson MO, Friberg LF. Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children. Cancer Chemother Pharmacol. 2024. doi:10.1007/s00280-024-04678-0 |

Kontakt
Omar Zaher Klinische Pharmazie T: +49/681/302-2284 |